Proxmed is pioneering next-generation clinical trials. We provide open access to AI-powered analytics, advanced imaging integration, and patient-first clinical trial design.
At Proxmed, our goal is to redefine healthcare intelligence and bring medicine to impact millions across the globe in a way that is personalised, streamlined, and accessible by challenging the status quo.
Dedicated study pods orchestrate Phase I–IV design, start-up, and closeout with scientific oversight built in.
Global regulatory strategists harmonise submissions across FDA, EMA, PMDA, and emerging markets without delays.
Hybrid recruitment, decentralised touchpoints, and concierge retention keep patients engaged from consent to database lock.
Get in touch →Risk-based monitoring, AI-powered cleaning, and adaptive analytics put real-time decisioning in sponsor hands.
We help teams accelerate discovery and care with secure, compliant and integrated capabilities — clinical trials, AI/ML, telehealth, consultancy, medical devices, and pharmaceutical innovation.
End-to-end clinical trial management powered by automation, ensuring compliance, confidentiality, and seamless integration from imaging to analytics.





